Latest Blog Posts Tagged "Research News"
July 21, 2016
A recent study led by Dr. J. Timothy Greenamyre, a member of our scientific advisory board, sheds new light on the connection between alpha-synuclein and the degeneration of cells in Parkinson's.
July 12, 2016
Today MJFF, the Van Andel Research Institute and the Cure Parkinson's Trust announced plans to collaborate to assess the clinical use and development of cancer drug nilotinib.
June 27, 2016
The Safety of Urate Elevation in Parkinson's Disease Phase III study (SURE-PD3) is in the final stage of clinical testing.
June 17, 2016
Discovery of this gene provides a new potential therapeutic target for PD treatment.
June 13, 2016
Today the Foundation announced a $2 million prize to motivate the research field to develop an imaging tracer to visualize alpha-synuclein in the brain and help test therapies to slow or stop disease.
June 08, 2016
Today MJFF announced a challenge asking data scientists and computational analysts to work with researchers to answer fundamental questions about Parkinson's disease.
June 01, 2016
Today MJFF and Georgetown University announced MJFF is funding a fellowship for training to optimize clinical trial design and support approval of novel therapies.
May 31, 2016
Nuplazid, a drug indicated for the treatment of Parkinson's disease psychosis, is now available for prescription.
May 25, 2016
Today the Foundation announced funding for two projects leveraging the promise of engineered stem cells to speed new therapies and deeper understanding of Parkinson's disease.
April 29, 2016
The Food and Drug Administration has approved Nuplazid to treat Parkinson's psychosis.